Compare MITT & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MITT | SWKH |
|---|---|---|
| Founded | 2011 | 1996 |
| Country | United States | United States |
| Employees | N/A | 9 |
| Industry | Real Estate Investment Trusts | Diversified Financial Services |
| Sector | Real Estate | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.7M | 198.4M |
| IPO Year | N/A | N/A |
| Metric | MITT | SWKH |
|---|---|---|
| Price | $7.44 | $17.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $9.25 | ★ $18.00 |
| AVG Volume (30 Days) | ★ 325.1K | 7.7K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | ★ 12.60% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.09 | N/A |
| Revenue Next Year | $4.69 | N/A |
| P/E Ratio | $9.34 | ★ $9.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.63 | $13.00 |
| 52 Week High | $9.27 | $18.66 |
| Indicator | MITT | SWKH |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 48.74 |
| Support Level | $7.03 | $16.65 |
| Resistance Level | $7.86 | $17.08 |
| Average True Range (ATR) | 0.25 | 0.30 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 23.72 | 64.21 |
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. The company focuses on its investment activities on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market.
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.